Experience with mildronate in cerebrovascular diseases

Abstract

Over the past years, results of various clinical trials of drugs demonstrating their efficacy in the treatment of cardiovascular diseases have been published. The article discusses the results of clinical use of Mildronate (meldonium) in the treatment of ischemic brain injuries; the results of trials show that the medicine has a cytoprotective effect on a number of pathogenic factors determining ischemic cell death in the brain.

Keywords

• цереброваскулярная болезнь
• ишемический инсульт
• нейропротективная терапия
• мельдоний
• cerebrovascular disease
• ischemic stroke
• neuroprotective therapy
• meldonium